Europe's €32.4 Billion Tech Surplus Runs on a Narrow Product Mix

The European Union exported €566.5 billion of high-tech goods in 2025 and imported €534.1 billion, producing a €32.4 billion surplus. The balance stayed positive for a second year after four consecutive deficits, according to Eurostat's 6 October release.

The composition is less comfortable. Pharmaceuticals generated a €113.6 billion surplus. Electronics and telecommunications lost €73.2 billion, while computers and office machines lost €57.7 billion. The headline shows strength in selected advanced manufacturing. It does not establish autonomy in the hardware that carries digital services and AI workloads.

The reversal is real, and nominal

Eurostat's September extraction records the following gross extra-EU trade values in current euros:

Imports rose €239.9 billion over the decade. Exports rose €265.4 billion. Yet the series measures border values, not inflation-adjusted output. Eurostat defines trade value as the amount at the border, with exports valued on a free-on-board basis and imports on a cost-insurance-freight basis. Quantity is a separate variable in the detailed data. The published comparison does not divide the annual changes among physical volume, unit prices or exchange rates.

That limitation matters most around the 2022 deficit and the subsequent reversal. The value series can establish that the balance changed. It cannot show that Europe produced more units, paid less per imported unit or gained capacity across the supply chain.

Three groups carry the aggregate

The nine-group classification makes the concentration visible. Pharmacy exported €206.9 billion against €93.2 billion of imports. Aerospace added a €25.2 billion surplus, and scientific instruments added €20.8 billion. Together, those three groups produced €159.6 billion of positive balance.

Every other group combined subtracted €127.2 billion. Non-electrical machinery contributed €7.1 billion and chemistry €2.4 billion. Those gains were overwhelmed by deficits in electronics, computers, electrical machinery and armament. Without pharmacy, the EU would have recorded an €81.3 billion high-tech deficit.

The improvement from 2024 was also concentrated. The overall balance increased by €9.6 billion. Pharmacy's surplus increased by €19.3 billion, more than twice the aggregate gain, while weaker balances in aerospace, computers, chemistry and armament absorbed much of the increase. Electronics improved by €4.3 billion but remained deeply negative.

Eurostat's high-tech classification groups products by research and development intensity. Its nine groups include medicines and aircraft alongside semiconductors, telecommunications equipment and computers. That breadth is analytically useful. It also means the aggregate cannot stand in for digital self-sufficiency.

China exposes the digital gap

China supplied €150.4 billion, or 28.2%, of EU high-tech imports in 2025. The United States supplied another €131.4 billion, or 24.6%. The top 12 partners accounted for 90% of imports, according to Eurostat's product and partner analysis.

The Chinese mix was concentrated where the EU-wide balance was weakest. Electronics and telecommunications represented 48% of imports from China. Computers and office machines represented 31%. At product level, the EU ran deficits with China of €57.5 billion in electronics and €45.0 billion in computers. The combined €102.5 billion gap was roughly equal to the total €102.3 billion high-tech deficit with China after smaller product surpluses and deficits offset one another.

Export concentration points in a different direction. The United States bought €195.1 billion, or 34.4%, of EU high-tech exports. Pharmaceuticals represented 62% of that flow. The EU's €63.7 billion surplus with the United States included a €77.2 billion pharmaceutical surplus that more than covered a €24.9 billion aerospace deficit.

The asymmetry extends beyond the largest partners. The top 20 origins supplied 97% of high-tech imports, while the top 20 destinations took 86% of exports. That does not by itself measure substitutability or strategic risk. It does show that the EU's import base is more concentrated than its export customer base. Product-level dependence, particularly in electronics and computers, is therefore more informative than the aggregate balance.

This is not a story of Europe importing everything and making nothing. It is a story of two different specialisations. Europe sells medicines, aircraft and instruments at scale. It remains a large net buyer of the electronic and computing equipment beneath its digital economy.

Production is not domestic value added

Eurostat also reports €532.4 billion of EU high-tech sold production in 2025, up from €287.3 billion in 2015. Pharmacy accounted for €166.7 billion, electronics and telecommunications €99.6 billion, scientific instruments €96.6 billion and aerospace €64.8 billion.

That €532.4 billion cannot be netted directly against €566.5 billion of exports. PRODCOM defines sold production as production carried out and invoiced during the reference period. The trade series records goods crossing the EU border at gross value. It can include imported intermediate inputs embodied in exports, and goods processed across several countries. Eurostat also notes that some COMEXT high-tech products have no corresponding PRODCOM classification.

Exporter location is therefore not the same as product origin or EU value added. Conventional trade data follow border flows. A value-added account must trace domestic and foreign inputs through production. Eurostat's FIGARO framework does that separately, but its published industry data currently end in 2024 and do not reproduce this nine-product 2025 balance.

The surplus remains useful evidence. It shows that European high-tech exports exceeded imports at recorded border values. A claim about autonomy needs more: quantities, unit prices, detailed origin concentration, re-exports and domestic value added. On those tests, the aggregate is a starting point, not a conclusion.